Researchers believe their findings could provide new insights into personalized medicine and treatments for specific disorders.
Anthracycline based chemotherapies could have greater negative effects on cognition than nonanthracycline treatments for breast cancer survivors, a new study reports.
A new study reports the locus coeruleus, an area of the brain essential for maintaining cognitive function, is vulnerable to toxins and infections. This brain area appears to be the first place affected by late onset Alzheimer's.
Researchers have discovered another purpose for the gut-brain axis; relaying information to the hippocampus to store information about our environment and location.
When intense feelings of prediction accompanied deja vu, they were strongly correlated with feelings of postdiction. High degrees of familiarity that accompany deja vu also carry through to postdictive bias.
Researchers report dysfunctional mitophagy may contribute to the development of Alzheimer's disease. When mitophagy is improved, symptoms of Alzheimer's almost disappeared in animal models of the disease.
MicroRNA-132 regulates neurogenesis in the hippocampus, according to both mouse and human tissue studies. Restoring levels of microRNA-132 in mouse models of Alzheimer's disease reduces neurogenetic deficits and restores cognitive abilities, researchers say.
Researchers take a deeper look at synesthesia, revealing the condition could be linked to some autoimmune diseases. The paper also reports synesthetes have better memory and are more creative than those without the disorder.
Researchers discover so-called sticky synapses can impair new learning by excessively hard wiring old memories.
Both the default mode network and salience network in superagers had stronger connectivity than typical older adults and similar connectivity as younger adults. Superagers performed similarly to young adults and better than typical older adults in recognition and episodic memory tasks.
Study identifies a different set of individual neurons in the medial frontal cortex that is responsible for memory-based decision making. The findings have implications for the treatment of Alzheimer's disease, schizophrenia, and other disorders associated with problems in cognitive flexibility.